In addition, serum levels of inflammation-related biomarkers (interleukin-6, serum ferritin, C-reactive protein) and coagulation parameter (D-dimer) are higher in COVID-19 patients with underlying diabetes mellitus compared with those without, suggesting that people with diabetes are more susceptible to cytokine storm ultimately leading to ARDS and rapid deterioration [9].